Fred Hutchinson Cancer Research Center

News Release

Study confirms limited human-to-human spread of avian-flu virus in Indonesia in 2006 »
Welcome to the new Vaccine and Infectious Disease Institute (VIDI). On May 1, 2007, Fred Hutchinson Cancer Research Center announced the creation of the Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria, and the viruses and bacteria that can result in cancer.

"Over the past decade, many Hutchinson Center scientists have gained international stature in the prevention of global infectious diseases, especially HIV, but also including human papillomavirus, malaria, Epstein-Barr virus, and other microbes," said Lee Hartwell, Ph.D., president and director of the Hutchinson Center. "The development of this new interdisciplinary institute within the Center acknowledges this strength and will help it flourish."

Population Sciences, including the Statistical Center for HIV and AIDS Research and Prevention (SCHARP); Infectious Disease Sciences, including HIV Vaccine Trials Network (HVTN); and Immunology and Vaccine Development, now constitute VIDI. Please refer to the programs section for a list of programs and departments.

Tackling global health issues requires bringing together the talents and resources of people and institutions around the world. The key goal of VIDI is to solve global health problems by recruiting and retaining leading scientists in the areas of vaccine development and prevention of infectious diseases. A second goal is to facilitate the Center's ability to partner with others in the region in the creation of a regional vaccine alliance that will make Seattle and Washington State an international leader in global infectious-disease prevention.


Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2008 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.